UNICREDIT BANK/CALL/NOVO-NORDISK B/1300/0.1/18.06.25 Share Price

Warrant

DE000HD1QYL8

Market Closed - BOERSE MUENCHEN 01:15:23 31/05/2024 am IST
0.56 EUR +5.66% Intraday chart for UNICREDIT BANK/CALL/NOVO-NORDISK B/1300/0.1/18.06.25
Current month-9.68%
1 month-9.68%
Date Price Change
30/24/30 0.56 +5.66%
29/24/29 0.53 -3.64%
28/24/28 0.55 -3.51%
27/24/27 0.57 -6.56%
24/24/24 0.61 -3.17%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 01:15 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer UniCredit UniCredit
WKN HD1QYL
ISINDE000HD1QYL8
Date issued 08/01/2024
Strike 1,300 kr
Maturity 18/06/2025 (384 Days)
Parity 10 : 1
Emission price 0.38
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.88
Lowest since issue 0.25
Delta0x
Omega 0.000000
Premium0x
Gearing22.96x
Moneyness 0.7053
Difference Strike 383.1 kr
Difference Strike %+29.47%
Spread 0.25
Spread %37.88%
Intrinsic value 0.000000
Present value 0.5350

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
916.9 DKK
Average target price
917.2 DKK
Spread / Average Target
+0.04%
Consensus